YuhanUSA and Huinno Partner to Launch AI-Powered ECG Monitoring in the U.S.
YuhanUSA, the U.S. subsidiary of Yuhan Corporation, announced on the 30th that it has signed a strategic business agreement with Huinno to spearhead...
Biowatch
A Major Paradigm Shift in Cholesterol Management: Earlier Testing, 30-Year Risk Predictions
Heart disease often appears as a sudden crisis, but it is typically the result of risks that have quietly accumulated within blood vessels over...
Vabysmo Prefilled Syringe Gains Reimbursement, Expanding Retina Treatment Options
Injectable therapies for chronic eye diseases are entering a new era where clinicians and patients can select...
Sam Chun Dang Pharm Secures Exclusive U.S. Licensing Deal for Oral Obesity and Diabetes Treatment
Sam Chun Dang Pharm has entered into a significant license-out agreement with an undisclosed U. S.
Celltrion Secures Japanese Approval for Xolair and Eylea Biosimilars
Celltrion announced on the 27th that it has obtained marketing authorization from Japan’s Ministry of Health, Labour...
Celltrion to Double Production Capacity with 1.2 Trillion Won Investment
Celltrion has announced a massive expansion across three of its major facilities in South Korea and the United States,...
GC Wellbeing Launches ECM Skin Booster ‘GCELLE Ribonne’
GC Wellbeing announced on the 25th that it has officially launched "GCELLE Ribonne" in Korea, a skin booster based on...
Daewoong Pharmaceutical to Distribute 'The Spirokit' Digital Pulmonary Function Tester
As pulmonary function testing is officially integrated into standard general health checkups this year, Daewoong...
Korea’s 40th New Drug ‘Nuviju’ Launches: A Three-Way Battle for the Double-Chin Market
Medytox is set to shake up the aesthetic medicine industry with the launch of "Nuviju," a new treatment for submental...
ABL Bio to Present Two Bispecific Antibody ADC Posters at AACR
ABL Bio announced on the 19th that it will participate in this year’s American Association for Cancer Research Annual...